Activin and Inhibin

BRD-6929 is a potent, selective brain-penetrant inhibitor of class I histone deacetylase HDAC1 and HDAC2 inhibitor with IC 50 of 1 nM and 8 nM, respectively. BRD-6929 shows high-affinity to HDAC1 and HDAC2 with K i of 0.2 and 1.5 nM, respectively.

BRD-6929 is a potent, selective brain-penetrant inhibitor of class I histone deacetylase HDAC1 and HDAC2 inhibitor with IC 50 of 1 nM and 8 nM, respectively. BRD-6929 shows high-affinity to HDAC1 and HDAC2 with K i of 0.2 and 1.5 nM, respectively.

BRD-K98645985 is a BAF (mammalian SWI/SNF) transcriptional repression inhibitor with an EC 50 of ~2.37 µM. BRD-K98645985 binds ARID1A-specific BAF complexes, prevents nucleosomal positioning, and potently reverses HIV-1 latency, without T cell

BRD-K98645985 is a BAF (mammalian SWI/SNF) transcriptional repression inhibitor with an EC 50 of ~2.37 µM. BRD-K98645985 binds ARID1A-specific BAF complexes, prevents nucleosomal positioning, and potently reverses HIV-1 latency, without T cell

BRD0639 is a first-in-class inhibitor of the PRMT5-substrate adaptor interaction . BRD0639 is a PRMT5 binding motif (PBM)-competitive agent that can support studies of PBM dependent PRMT5 activities.Appearance:SolidIn Vitro:BRD0639 is a

BRD0639 is a first-in-class inhibitor of the PRMT5-substrate adaptor interaction . BRD0639 is a PRMT5 binding motif (PBM)-competitive agent that can support studies of PBM dependent PRMT5 activities.Appearance:SolidIn Vitro:BRD0639 is a

BRD0639 is a first-in-class inhibitor of the PRMT5-substrate adaptor interaction . BRD0639 is a PRMT5 binding motif (PBM)-competitive agent that can support studies of PBM dependent PRMT5 activities.Appearance:SolidIn Vitro:BRD0639 is a

BRD0639 is a first-in-class inhibitor of the PRMT5-substrate adaptor interaction . BRD0639 is a PRMT5 binding motif (PBM)-competitive agent that can support studies of PBM dependent PRMT5 activities.Appearance:SolidIn Vitro:BRD0639 is a

BRD0639 is a first-in-class inhibitor of the PRMT5-substrate adaptor interaction . BRD0639 is a PRMT5 binding motif (PBM)-competitive agent that can support studies of PBM dependent PRMT5 activities.Appearance:SolidIn Vitro:BRD0639 is a

BRD0639 is a first-in-class inhibitor of the PRMT5-substrate adaptor interaction . BRD0639 is a PRMT5 binding motif (PBM)-competitive agent that can support studies of PBM dependent PRMT5 activities.In Vitro:BRD0639 is a first-in-class

BRD5529 is an effective dose-dependent CARD9-TRIM62 protein–protein interaction (PPI) inhibitor with an IC 50 value of 8.6 μM. BRD5529 has potency and complete inhibition of CARD9 ubiquitinylation in vitro, also has favorable solubility. BRD5529 can

BRD5529 is an effective dose-dependent CARD9-TRIM62 protein–protein interaction (PPI) inhibitor with an IC 50 value of 8.6 μM. BRD5529 has potency and complete inhibition of CARD9 ubiquitinylation in vitro, also has favorable solubility. BRD5529 can